Abatacept (Orencia) is a novel infusion for the treatment of rheumatoid arthritis

被引：0
|
作者：
Nolan, Mark
机构：
来源：
EJHP PRACTICE | 2008年 / 14卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：85 / 85
页数：1
相关论文
共 50 条
  • [21] Cost-effectiveness of rituximab (Mabthera) compared with abatacept (Orencia) for the treatment of moderate/severe rheumatoid arthritis (RA) in the united kingdom
    Lewis, G.
    Kielhorn, A.
    Diamantopoulos, A.
    VALUE IN HEALTH, 2007, 10 (06) : A249 - A250
  • [22] Efficacy of the Subcutaneous Formulation of Abatacept/Orencia in Rheumatoid Arthritis, a Single-Center Italian Experience.
    Reggia, Rossella
    Franceschini, Franco
    Tincani, Angela
    Cavazzana, Ilaria
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S675 - S675
  • [23] Abatacept: a costimulatory inhibitor for treatment of rheumatoid arthritis
    Teng, GG
    Turkiewicz, AM
    Moreland, LW
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2005, 5 (09) : 1245 - 1254
  • [24] Drug Insight: abatacept for the treatment of rheumatoid arthritis
    Ruderman, Eric M.
    Pope, Richard M.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (12): : 654 - 660
  • [25] Drug Insight: abatacept for the treatment of rheumatoid arthritis
    Eric M Ruderman
    Richard M Pope
    Nature Clinical Practice Rheumatology, 2006, 2 : 654 - 660
  • [26] Update on the use of abatacept for the treatment of rheumatoid arthritis
    Vicente Rabaneda, Esther F.
    Herrero-Beaumont, Gabriel
    Castaneda, Santos
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (07) : 599 - 621
  • [27] PReS-FINAL-2138: Abatacept (orencia) in treatment of different types of juvenile idiopathic arthritis
    ES Zholobova
    OU Konopelko
    LA Galstyan
    OS Rozvadovskaya
    MN Nikolaeva
    Pediatric Rheumatology, 11 (Suppl 2)
  • [28] Health care professional survey to assess the effectiveness of abatacept (Orencia®) patient alert cards in rheumatoid arthritis patients
    Artime, Esther
    Kahlon, Randip
    Qizilbash, Nawab
    Mendez, Ignacio
    Kou, Tzuyung
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 519 - 519
  • [29] Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry
    Salmon, J. H.
    Gottenberg, J. E.
    Ravaud, P.
    Cantagrel, A.
    Combe, B.
    Flipo, R. M.
    Schaeverbeke, T.
    Houvenagel, E.
    Gaudin, P.
    Loeuille, D.
    Rist, S.
    Dougados, M.
    Sibilia, J.
    Le Loet, X.
    Meyer, O.
    Solau-Gervais, E.
    Marcelli, C.
    Bardin, T.
    Pane, I.
    Baron, G.
    Perrodeau, E.
    Mariette, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (06) : 1108 - 1113
  • [30] Abatacept for rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2020, 2 (03): : E134 - E134
12345